Filter posts

BIO Investor Forum Company Snapshot: Opsona Therapeutics

Opsona Therapeutics will be participating in the upcoming BIO Investor Forum, and will be giving …

Putting Patients First: Paving a Path to Useful CER

Comparative effectiveness research (CER) has the potential to improve health outcomes by helping people make …

Hawaiian State Legislature’s Selective Memory toward Papaya Saving Science

In recent years, the papaya fruit has become a leading export for the island of …

FDA Consumer Update: Advances in Saving Lives with Blood

Every two seconds in the U.S., someone needs a blood transfusion or blood product—people of …

Exploring New Solutions For Neglected Diseases in Developing Countries

On Tuesday, BIO Ventures for Global Health (BVGH) announced the completion of the 30th research agreement …

2013 BIO Convention in China Facilitates East-West Partnering in Biotech

Now in its third year, the BIO Convention in China will be held November 11-13, …

India’s IP Policy: India’s Lead Biotech Innovator Expresses Concern

Kiran Mazumdar-Shaw, chairperson and managing director of India’s largest biotechnology company Biocon, expressed concern with …

BioCentury This Week: Death & Taxes – Startups Need Fixes

Vitae CEO Jeff Hatfield, Ernst & Young Partner Christopher Ohmes, and GPB Scientific CEO Michael …

"Let’s Take Advantage of It," Biotech in the US-EU Trade Agreement

As the second round of the Transatlantic Trade and Investment Partnership (TTIP) talks approach Brussels …

BIO Investor Forum Company Snapshot: Vaccinex

Recently, the CEO of Prosensa provided their company’s perspective participating in last year’s BIO Investor Forum. …